XBIT: XBiotech Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling $711K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 36 | XBIT | XBiotech Inc. | Simard John | Director | 2026-10-26 | $711K | 10% |
Institutional ownership (Q2 2026)
36 institutions reported holding $4.49M of XBiotech Inc. on Form 13F (37 the quarter before). 3 opened a new position and 3 sold out. Shares held by institutions: -2%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 321,146 | $739K |
| GEODE CAPITAL MANAGEMENT, LLC | 214,116 | $493K |
| VANGUARD CAPITAL MANAGEMENT LLC | 200,182 | $460K |
| RBF Capital, LLC | 198,501 | $457K |
| MORGAN STANLEY | 147,880 | $340K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 98,447 | $226K |
| VANGUARD FIDUCIARY TRUST CO | 92,365 | $212K |
| MILLENNIUM MANAGEMENT LLC | 79,330 | $182K |
| STATE STREET CORP | 73,006 | $168K |
| NORTHERN TRUST CORP | 66,258 | $152K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.